When did Mirum Pharmaceuticals, Inc. report Q4 2024 earnings?

Mirum Pharmaceuticals, Inc. (MIRM) reported Q4 2024 earnings on February 26, 2025 after market close.

What were Mirum Pharmaceuticals, Inc.'s Q4 2024 revenue and EPS?

Mirum Pharmaceuticals, Inc. reported revenue of $99.4M and eps of $-0.49 for Q4 2024.

Did Mirum Pharmaceuticals, Inc. beat estimates in Q4 2024?

Revenue beat the consensus estimate of $96.6M by $2.8M. EPS missed the consensus estimate of $-0.27 by $0.22.

Where can I find Mirum Pharmaceuticals, Inc.'s Q4 2024 SEC filings?

You can read the 10-K periodic report (0001759425-25-000014) directly on SEC EDGAR. The filing index links above go to sec.gov.

Mirum Pharmaceuticals, Inc. MIRM Q4 2024 Annual earnings

Reported February 26, 2025 · After market close

Revenue$99.4MBeat by $2.8M

EPS-$0.49Miss by $0.22

Revenue estimate$96.6M

EPS estimate-$0.27

Next report

Jul 30, 2026 (Tomorrow)

Revenue estimate$166.0M

EPS estimate-$0.73

Financials

Q4 2024

Income statement

See full

Revenue$99.4M+42.9%

Operating income-$24.2M+25.7%

Net income-$23.8M+33.3%

EPS (diluted)-$0.49+31.9%

Balance sheet

See full

Cash & equivalents$203.0M-27.0%

Total debt$9.7M+463%

Total equity$225.6M-9.3%

Total assets$670.8M+3.7%

Cash flow

See full

CapEx$20.0K—

Valuation & ratios

Valuation

as of 12/31/24

See full

Market cap$1.98B+43.9%

Enterprise value$1.79B+62.5%

P/S5.9×-1.5×

Profitability

See full

Operating margin-26%-9.3pp

Net margin-26.1%-10.8pp

Returns & leverage

See full

Return on equity-37.1%-13.3pp

Debt / equity0×0.0×

Current ratio3.1×-1.3×

Segments

By product

See full

Livmarli$64.1M+54.5%

Bile Acid Medicines$35.3M+25.9%

Versus estimates

Revenue

Q1 2026$159.9MBeat by $11.7M Q4 2025$148.9MBeat by $6.4M Q3 2025$133.0MMiss by $7.9M Q2 2025$127.8MMiss by $2.3M Q1 2025$111.6MBeat by $13.2M

Q4 2024$99.4MBeat by $2.8M

Diluted EPS

Q1 2026-$13.43Miss by $13.03 Q4 2025-$0.11Miss by $0.13 Q3 2025$0.05Beat by $0.15 Q2 2025-$0.12Beat by $0.19 Q1 2025-$0.30Beat by $0.09

Q4 2024-$0.49Miss by $0.22

Ask the moment Mirum Pharmaceuticals, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI

Claude

Questions, answered.

When did Mirum Pharmaceuticals, Inc. report Q4 2024 earnings?: Mirum Pharmaceuticals, Inc. (MIRM) reported Q4 2024 earnings on February 26, 2025 after market close.
What were Mirum Pharmaceuticals, Inc.'s Q4 2024 revenue and EPS?: Mirum Pharmaceuticals, Inc. reported revenue of $99.4M and eps of $-0.49 for Q4 2024.
Did Mirum Pharmaceuticals, Inc. beat estimates in Q4 2024?: Revenue beat the consensus estimate of $96.6M by $2.8M. EPS missed the consensus estimate of $-0.27 by $0.22.
Where can I find Mirum Pharmaceuticals, Inc.'s Q4 2024 SEC filings?: You can read the 10-K periodic report (0001759425-25-000014) directly on SEC EDGAR. The filing index links above go to sec.gov.